Publicacións en colaboración con investigadores/as de Tel Aviv University (4)

2020

  1. BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years

    European Journal of Haematology, Vol. 104, Núm. 6, pp. 594-601

  2. Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

    Leukemia

  3. Second cancers in MPN: Survival analysis from an international study

    American Journal of Hematology, Vol. 95, Núm. 3, pp. 295-301

2019

  1. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

    Leukemia, Vol. 33, Núm. 8, pp. 1996-2005